A phase I/IIa, double-blind, randomized, placebo-controlled study of antiviral agent in patients with chronic hepatitis B infection to investigate the safety, pharmacokinetics and antiviral activity of ascending 4-week oral doses of LB80380


Grant Data
Project Title
A phase I/IIa, double-blind, randomized, placebo-controlled study of antiviral agent in patients with chronic hepatitis B infection to investigate the safety, pharmacokinetics and antiviral activity of ascending 4-week oral doses of LB80380
Principal Investigator
Dr Yuen, Richard Man Fung   (Principal investigator)
Duration
24
Start Date
2004-04-01
Completion Date
2006-03-31
Amount
430000
Conference Title
Presentation Title
Keywords
Chronic Hepatitis B
Discipline
Gastroenterology/Hepatobiliary
Sponsor
Other projects
Grant Type
LG Life Sciences, Ltd. - General Award
Funding Year
2003/2004
Status
Completed